Generation change 4.0 at Ottobock
German medtech company sets course for future
Prof. Hans Georg Näder's youngest daughter, Georgia, will in future be representing the family on Ottobock's supervisory board, which is currently being formed. Otto Bock HealthCare GmbH, based in the German state of Lower Saxony, is undergoing the conversion to an SE & Co. KGaA. Georgia Näder will therefore also be enlisted to the executive board of Otto Bock Holding GmbH & Co. KG.
Following nearly three decades in his role as CEO at Otto Bock HealthCare GmbH, Prof. Hans Georg Näder (56) will be assuming the leadership of the supervisory board of the future Ottobock SE & Co. KGaA as chairman of the board. Dr Oliver Scheel (49) will take over the role of CEO on 15 January 2018.
The appointment of Dr Scheel, a long-time partner and managing director at consulting company A.T. Kearney and head of their pharma, medical technology and healthcare department who possesses extensive expertise in the subject of transformation management, represents the first time in Ottobock's history that a manager from outside the family has taken the helm of the German-based "hidden champion" and global market leader in the field of technical orthopaedics.
Longstanding CFO Harry Wertz (60) will exclusively continue his role as CEO with the Otto Bock Holding GmbH & CoKG.
The head of the Näder Family Office, Stefan Hirsch (45), was also enlisted to the executive board of Otto Bock Holding GmbH & Co. KG as part of the developments within the company.
Further information: http://ots.de/oCngf
Head of Investor Relations / Corporate Communications
Mark C. Schneider
Phone: +49 (0) 30 398 206 222 / mobile: +49 (0) 151 146 591 35
Original content of: Ottobock SE & Co. KGaA, transmitted by news aktuell